History
  • No items yet
midpage
307 A.3d 998
Del. Ch.
2023
Read the full case

Background

  • AIM ImmunoTech is a microcap immuno-pharma with a history of activist attention after a failed 2022 proxy effort in which a nominal stockholder (Jorgl) fronted a nominee while others (including Franz Tudor and Todd Deutsch) were involved behind the scenes.
  • In March 2023 AIM’s Board adopted amended advance-notice bylaws (Amended Bylaws) to address perceived activist concealment and to conform to universal-proxy developments; amendments added broad disclosure obligations including a defined "Stockholder Associated Person (SAP)", a 24‑month AAU lookback, expanded ownership/derivative reporting, known‑supporter disclosures, and nominee questionnaires.
  • Ted Kellner (with Deutsch and Chioini) submitted a last‑minute nomination (the Kellner Notice) for himself and two nominees; AIM’s Board rejected the notice as noncompliant with the Amended Bylaws, principally for failing to disclose arrangements/understandings (AAUs) and other information.
  • Kellner sued seeking (1) to invalidate the Amended Bylaws as adopted, (2) a declaration that the Board unlawfully rejected his notice, and (3) fiduciary‑breach relief; AIM counterclaimed to uphold the Amended Bylaws. The matter was tried.
  • The court applied enhanced/unocal-style scrutiny: it held the Board had a legitimate, reasonable information‑gathering objective but invalidated several Amended Bylaw provisions as overbroad and inequitable; separately, the court found Kellner’s nomination materially misrepresented/omitted AAUs under the prior (2016) bylaw and lawfully rejected the notice.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Validity of Amended Bylaws (adoption/fiduciary claim) Kellner: Board amended bylaws to thwart activism and entrench incumbents; adoption was inequitable and breaches fiduciary duties AIM: Amendments were reasonable, responsive to 2022 abuse and to universal‑proxy rule, and aimed at proper disclosure Enhanced scrutiny applied; Board identified a legitimate threat, but several specific provisions (SAP‑expanded AAU, Consulting/Nomination, Known‑Supporter, and overly broad Ownership disclosure) were disproportionate and invalid; remainder of Amended Bylaws upheld
Whether Kellner's notice complied with AAU disclosure Kellner: No pre‑existing AAU; notice was truthful and compliant AIM: Notice omitted/misstated material arrangements and first‑contact dates showing coordinated, continuing effort from 2022 into 2023 Court reverted to 2016 AAU standard (since parts of 2023 AAU invalid); found tacit arrangements and preparatory measures pre‑dating July 2023; Kellner’s assertions were false/omitted material AAUs—notice noncompliant
Equitable application of bylaws / Board conduct Kellner: Board prejudged, manipulated questionnaire timing, and applied bylaws inequitably AIM: Board retained independent counsel, investigated, and reasonably enforced valid requirements Board acted reasonably and proportionately in light of 2022 history; changes to questionnaire and process not evidence of manipulation; rejection equitable and lawful
Remedy scope (void all vs. sever limited provisions; ballot relief) Kellner: Entire Amended Bylaws invalid; place nominees on 2023 ballot AIM: Amended bylaws are valid in whole and rejection should stand Court struck specific overbroad provisions as "of no force and effect" but did not void the Amended Bylaws in their entirety; rejection of Kellner Notice sustained and nominees not placed on ballot

Key Cases Cited

  • EMAK Worldwide, Inc. v. Kurz, 50 A.3d 429 (Del. 2012) (recognizing shareholder franchise rights to vote and nominate directors)
  • Blasius Indus., Inc. v. Atlas Corp., 564 A.2d 651 (Del. Ch. 1988) (board action that interferes with stockholder franchise triggers heightened scrutiny)
  • Unitrin, Inc. v. American General Corp., 651 A.2d 1361 (Del. 1995) (standard for evaluating board defensive measures for proportionality)
  • Schnell v. Chris‑Craft Industries, Inc., 285 A.2d 437 (Del. 1971) (equity will enjoin use of corporate machinery to frustrate shareholder rights)
  • Coster v. UIP Companies, Inc., 300 A.3d 656 (Del. 2023) (contemporary guidance folding Blasius and Schnell into Unocal‑style enhanced scrutiny)
  • Openwave Systems Inc. v. Harbinger Capital Partners Master Fund I, Ltd., 924 A.2d 228 (Del. Ch. 2007) (discussing advance‑notice bylaws’ role in orderly meetings and disclosure)
  • BlackRock Credit Allocation Income Tr. v. Saba Capital Master Fund, Ltd., 224 A.3d 964 (Del. 2020) (upholding informational role of advance notice provisions)
  • Air Products & Chemicals, Inc. v. Airgas, Inc., 16 A.3d 48 (Del. Ch. 2011) (Unocal prong‑2 proportionality inquiry in context of board defensive measures)
Read the full case

Case Details

Case Name: Kellner v. AIM Immunotech Inc.
Court Name: Court of Chancery of Delaware
Date Published: Dec 28, 2023
Citations: 307 A.3d 998; C.A. No. 2023-0879-LWW
Docket Number: C.A. No. 2023-0879-LWW
Court Abbreviation: Del. Ch.
Log In
    Kellner v. AIM Immunotech Inc., 307 A.3d 998